Limitations of a meta-analysis investigating the association between cancer and statin use [1] (multiple letters)

American Journal of Medicine

Volumn 112, Issue 2, 2002, Pages 157-158

  Iwata, Hiroshi ^a   Aoyama, Tomonori ^a   Kusumi, Eiji ^a   Hamaki, Tamae ^a   Kami, Masahiro ^a   Bjerre, Lise M ^b   LeLorier, Jacques ^c  

^a TORANOMON HOSPITAL   (Japan)

^b MCGILL UNIVERSITY   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CANCER INCIDENCE; CANCER INHIBITION; CANCER RISK; CARCINOGENICITY; CLINICAL TRIAL; DRUG USE; HUMAN; IMMUNE DEFICIENCY; LETTER; LONG TERM CARE; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; VALIDATION PROCESS;

EID: 0037083082     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(01)01040-3     Document Type: Letter

References (0)